This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Prometheus Research Awarded $700,000 NIH SBIR Grant To Improve Open Source Tools For Autism Research

NEW HAVEN, Conn., April 9, 2013 /PRNewswire/ -- Prometheus Research, an integrated data management services provider, announced today that it has been awarded $700,000 by the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) program to extend its Open Source Research Exchange Database (RexDB) for the management of autism spectrum disorders research. The project aims to empower autism investigators to make more effective use of their data and more efficiently exchange data across the scientific community.  

"RexDB is already the data collection, data warehousing, and data sharing software platform of choice for numerous longitudinal multidisciplinary research studies at leading academic research institutions. This Phase I grant will enable smaller labs and clinics to also leverage RexDB by funding the development of novel self-service technologies," explained Dr. Leon Rozenblit, CEO of Prometheus Research and Principal Investigator on the project.

The previous version of the Research Exchange Database was initially developed to meet the needs of the Simons Foundation Autism Research Initiative (SFARI) for use on their pioneering multi-site autism study, the Simons Simplex Collection (SSC). In that study, one dozen universities across North America collected and analyzed data from over 2,700 families with at least one child affected by autism. The resulting genetic and phenotypic repository, known as SFARI Base, also relies on RexDB technology. Since the SSC, RexDB has been adopted by leading academic research centers across the US to overcome the unique challenges of mental and behavioral health research.

Collaborating with Prometheus on the grant are the Yale University Child Study Center, the Marcus Autism Center, Weill Cornell Medical College, the University of Missouri Thompson Center, and others. SBIR grants are judged for scientific and technical merit, including significance of the problem being addressed, the innovative nature of the proposed solution, the overall strategy for execution, and the quality of the research team.

"RexDB will allow researchers to make better use of scarce research dollars, and thus help accelerate progress our understanding autism and other mental disorders," Dr. Rozenblit added. "We're honored that the NIH has chosen to support the next iteration of RexDB."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs